Showing results (2131-2140 of 4,053) with videos related to

Sort By:
Pageof 406
American Journal of Health Behavior|August 30, 2013
Social support among immigrant Latino men: a validation studyScott D Rhodes, Jason Daniel, Eun-Young Song, et al.
BMC Psychiatry|July 24, 2021
The role of mental health symptomology and quality of life in predicting referrals to special child and adolescent mental health servicesYeosun Yoon, Jessica Deighton, Alice Wickersham, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
Food Waste in Schools: A Pre-/Post-test Study Design Examining the Impact of a Food Service Training Intervention to Reduce Food WasteSara A Elnakib, Virginia Quick, Mariel Mendez, et al.
Histopathology|January 6, 2021
Amyloid in the breast: retrospective review with clinicopathological and radiological correlation of 32 cases from a single institutionLauren A Duckworth, Claudiu V Cotta, J Jordi Rowe, et al.
Psychological Medicine|February 9, 2022
Groundhog Day: research without old data and old referencesBarry A Hong, David E Pollio, Dana L Downs, et al.
Qualitative Health Research|October 12, 2018
Facilitators and Barriers of Participation in "Uptime" Activities in Girls and Women With Rett Syndrome: Perspectives From Parents and ProfessionalsMichelle Stahlhut, Bente Appel Esbensen, Jane Lunding Larsen, et al.
Biological Psychiatry|July 1, 1986
Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression?N S Downs, K T Britton, D M Gibbs, et al.
The International Journal on Drug Policy|June 27, 2020
Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approachTyler J Varisco, Callie G Downs, Kaycie R Rathburn, et al.
Applied Optics|March 24, 2010
Off-axis multipass amplifier as a large aperture driver stage for fusion lasersJ E Murray, D C Downs, J T Hunt, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
CI-943, a potential antipsychotic agent. I. Preclinical behavioral effectsT G Heffner, D A Downs, L T Meltzer, et al.
Pageof 406